受到全球需降脂治疗的潜在人数超过 2 95亿的强力驱动 ,目前降脂药物的世界销售总额已达 2 2 0亿美元以上 ,其中他汀类药物在该类药物市场中占有绝对支配地位。 2 0 0 2年 ,仅阿伐他汀 (atorvastatin)和辛伐他汀 (simvastatin)的全球销售额就已分别高达 79 72和 5 5 80亿美元 Driven by over 29.5 billion potential people with lipid-lowering treatment worldwide, the world sales of lipid-lowering drugs have now reached more than 220 billion U.S. dollars, of which statins have the absolute dominant position in the market for such drugs. In 2002, global sales of atorvastatin and simvastatin alone were as high as 79.72 and 55.8 billion U.S. dollars, respectively